Navigation Links
Unilens Launches New C-VUE(R) Advanced(TM) Custom Toric Lens
Date:11/5/2008

All New C-VUE Advanced Custom Toric Lens Now Available Through Licensed Eye

Care Professionals Only

LARGO, Fla., Nov. 5 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced the launch of the all new C-VUE(R) Advanced(TM) Custom Toric. The C-VUE Advanced Custom Toric will be sold directly to independent eye care professionals and features a revolutionary trial program, an advanced hydration material and exceptional deliverability (typically ships within in 2 to 3 days).

C-VUE Advanced Custom Toric is available in new convenient blister packaging with hioxifilcon D, a material which offers advanced hydration properties that allow it to retain 97% of its moisture resulting in all day comfort. The new product offering and hassle free trial/no returns necessary program will provide independent practitioners with an additional specialty C-VUE contact lens option that contributes to patient retention and practice profitability.

C-VUE Advanced Custom Toric is an easy to fit specialty toric contact lens, designed in an extremely wide range of customizable parameters with exceptional deliverability. The lens offers made to order base curves, diameters, powers and cylinders combined with axis in one degree steps.

"The launch of the C-VUE Advanced Custom Toric continues our tradition of providing outstanding specialty lens technology exclusively to licensed optical professionals," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "With our revolutionary Free Trial Program for custom lenses, we eliminate the time and expense of returning lenses, thereby increasing profitability to the Independent Eye Care Professional as well," concluded Mr. Pecora.

About Unilens Vision Inc. -- "The Independent Eye Care Professionals Contact Lens Company" '/>"/>

SOURCE Unilens Vision Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
2. Unilens Vision Reports Record First Quarter Earnings and Royalty Income
3. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
4. Unilens Vision Reports 70% Increase in Second Quarter Earnings on Higher Sales and Record Royalty Income
5. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
6. Unilens Launches Aspheric C-VUE(R) Daily Disposable Lens
7. Unilens Vision Reports Increased Royalty Income
8. Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability
9. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
10. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
11. UPMC Health Plan Launches New Personal Health Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 The nation’s ... lawsuit is nearing its conclusion in Washington state ... during closing statements yesterday, an attorney for the Plaintiffs ... company wanted to tie sales and services for its ... training to keep control of surgeons, to keep control ...
(Date:5/21/2013)... May 21, 2013 Go Classy Tours, ... that they have redesigned their website featuring N ... pool, hot tubs, bars and dining. The website, which ... including sales and guest reviews, will now have a ... itself, including pages on culinary local recipes, flora and ...
(Date:5/21/2013)... 21, 2013 While North Carolina is ... comprehensive travel guides. Brunswick Plantation & Golf Resort is ... include access to 27 holes of "Top10" championship golf. ... North Carolina, knowing the Top 10 from ... away the overwhelming task of selecting the course to ...
(Date:5/21/2013)... About one in six Australian couples suffer infertility, ... one of the fastest growing industries in the health ... conceive naturally through a variety of treatment options, the ... (IVF) cycles. Over the past five years, the number ... 4.4% per annum to a forecast 40,000 cycles in ...
(Date:5/21/2013)... Reporter , , TUESDAY, May 21 (HealthDay News) -- Swollen ... apnea in children, and while removing them did not ... did help them with sleep, behavior and quality of ... a condition that causes abnormal pauses in breathing during ... with the surgery, and those improvements were likely responsible ...
Breaking Medicine News(10 mins):Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Removing Tonsils Helps Kids With Sleep Apnea, Study Finds 2Health News:Removing Tonsils Helps Kids With Sleep Apnea, Study Finds 3
... Video games are now being considered seriously as a medical ... from obesity and dementia to cancer.// ,In the United ... and government policy makers to launch their ‘games for health’ ... video games as a treatment option by incorporating ...
... Needle phobia or fear of needles can be overcome ... according to researchers at the University of New Mexico's// ... of needles can impact the care a patient receives. ... sight of needles, whereas some adults avoid the doctor's ...
... The latest Government report in UK, states that British public ... third of the population will be obese within the next ... published by the Department of Health, earlier in the week, ... children would get very dangerously fat, and on all probabilities, ...
... Snaith, a couple travelling on a My Travel flight to ... son in Tenerife after the captain// of the plane refused ... on his head. The captain thought it was chicken pox. ... his mom had an interview to attend. My Travel's agent, ...
... King Jr./Drew Medical Center explained, that in the wake ... back the accreditation along with// restoration of the cut ... Epps, chief executive of the hospital, also spoke highly ... inculcate a sense of responsibility for the quality of ...
... breast cancer test, which could save several women from needless ... core needle biopsy to sample suspect breast tissue for microscopic ... of gene patterns in the sample. This may help in ... test has very little proof. ,Till date, the ...
Cached Medicine News:Health News:Britons Are Bloating! 2Health News:Britons Are Bloating! 3Health News:Novel test for diagnosis of breast cancer 2
(Date:5/21/2013)... , May 21, 2013 Sanofi (EURONEXT: ... REGN) today announced that the New England Journal ... study results of dupilumab (SAR231893/REGN668) in patients with moderate-to-severe ... the alpha subunit of the interleukin 4 receptor (IL-4R ... drivers of Th2 (Type 2 helper T cell) immune ...
(Date:5/21/2013)... -- U.S. spending on specialty prescription drugs — those ... multiple sclerosis and rheumatoid arthritis — is projected to ... to a forecast released today by Express Scripts (NASDAQ: ... "As we see what,s on the horizon, ... so they can continue to offer an affordable pharmacy ...
(Date:5/21/2013)... , May 21, 2013  AcelRx Pharmaceuticals, ... specialty pharmaceutical company focused on the development ... treatment of acute and breakthrough pain, today ... placebo-controlled Phase 3 study of its investigational ... (NanoTab System), the primary efficacy endpoint was ...
Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10
... REDWOOD CITY, Calif., May 6, 2011 AcelRx Pharmaceuticals, ... company focused on the development and commercialization of innovative ... today announced that Richard King, President and Chief Executive ... Research Conference at the San Francisco Ritz Carlton. The ...
... MIAMI, May 6, 2011 SaveRxCanada.com the premier Canadian pharmacy ... still purchase Canada drugs from a Canada pharmacy ... Canada drugs can be 85% less than the U.S. ... clientele since 2002. 2. Convenience – Many patients are ...
Cached Medicine Technology:AcelRx Pharmaceuticals to Present at the JMP Securities Research Conference 2Canadian Pharmacy Intermediary's Top Reasons U.S. Customers Choose Canada Online Pharmacies Revealed by SaveRxCanada.com 2
The Foundation PS knee offers a femoral option and tibial insert which provides a specially designed cam action that engages at 60 degrees of flexion to induce a smooth stable femoral roll-back motio...
... Natural Knee design includes several ... CSTi porous coating option for ... a unique bone preserving posterior ... groove to maximize range of ...
... Total Knee System provides anatomical replacement of ... while preserving the stabilizing Anterior and Posterior ... motion of the knee. All the components ... sizes and are equally proportioned and contoured ...
Advance Posterior Stabilized Total Knee systems improves patellofemoral kinematics, reduces wear rate potential, increases resistance to posterior tibial dislocation, achieves at least 120o flexion i...
Medicine Products: